Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study

J Am Acad Dermatol. 2018 Apr;78(4):801-803. doi: 10.1016/j.jaad.2017.09.067. Epub 2017 Oct 7.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Multicenter Study

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Drug-Related Side Effects and Adverse Reactions / epidemiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Randomized Controlled Trials as Topic
  • Retrospective Studies
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Time Factors
  • Treatment Refusal / statistics & numerical data*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Thalidomide
  • apremilast